\-\ Texto\\:\\ \ \(0\)\
\-\ 48\\ year\\ old\\ male\\ diagnosed\\ with\\ multiple\\ sclerosis\\ in\\ 1996\\.\\ at\\ that\\ time\\,\\ patient\\ presented\\ with\\ \\ right\\ lower\\ extremity\\ weakness\\,\\ ataxia\\,\\ spastic\\ gait\\,\\ and\\ decreased\\ visual\\ acuity\\ in\\ right\\ eye\\.\\ \\ lumbar\\ puncture\\ showed\\ 3\\ oligoclonal\\ bands\\,\\ 4\\ white\\ blood\\ cells\\,\\ 3\\ red\\ blood\\ cells\\ and\\ normal\\ glucose\\ and\\ protein\\.\\ mri\\ showed\\ t2\\ hyperintensities\\ and\\ scattered\\ enhancement\\.\ \(0\)\
\-\ \\ \\ \\ \\ \\ patient\\ now\\ presents\\ \\(2010\\)\\ with\\ progressively\\ worsening\\ symptoms\\ over\\ the\\ past\\ 4\\ months\\.\\ mri\\ was\\ ordered\\ to\\ evaluate\\ for\\ enhancing\\ plaques\\.\ \(0\)\
\-\ interferon\\ beta\\ 1\\-a\ \(0\)\
\-\ sagittal\\ and\\ axial\\ t1\\,\\ axial\\ t2\\,\\ coronal\\ and\\ sagittal\\ t2\\ fair\\ and\\ post\\ gadolinium\\ axial\\ images\\ through\\ the\\ brain\\ were\\ performed\\.\\ numerous\\ foci\\ of\\ periventricular\\,\\ periatrial\\ and\\ deep\\ white\\ matter\\ signal\\ abnormalities\\.\\ there\\ is\\ diffuse\\ foci\\ of\\ parenchymal\\ trophy\\.\\ there\\ are\\ additional\\ foci\\ of\\ signal\\ changes\\ within\\ the\\ subcortical\\ white\\ matter\\ of\\ the\\ bilaeral\\ hemispheres\\.\\ also\\ with\\ interval\\ development\\ of\\ several\\ new\\ lesions\\.\\ \\ following\\ contrast\\ administration\\,\\ multiple\\ enhancing\\ lesions\\ are\\ noted\\ in\\ the\\ right\\ frontal\\ and\\ parietal\\ lobes\\.\ \(0\)\
\-\ multiple\\ sclerosis\ \(41\)\
\-\ 48\\ year\\ old\\ male\\ diagnosed\\ with\\ multiple\\ sclerosis\\ in\\ 1996\\.\\ at\\ that\\ time\\,\\ patient\\ presented\\ with\\ \\ right\\ lower\\ extremity\\ weakness\\,\\ ataxia\\,\\ spastic\\ gait\\,\\ and\\ decreased\\ visual\\ acuity\\ in\\ right\\ eye\\.\\ \\ lumbar\\ puncture\\ showed\\ 3\\ oligoclonal\\ bands\\,\\ 4\\ white\\ blood\\ cells\\,\\ 3\\ red\\ blood\\ cells\\ and\\ normal\\ glucose\\ and\\ protein\\.\\ mri\\ showed\\ t2\\ hyperintensities\\ and\\ scattered\\ enhancement\\.\ \(0\)\
\-\ \\ \\ \\ \\ \\ patient\\ now\\ presents\\ \\(2010\\)\\ with\\ progressively\\ worsening\\ symptoms\\ over\\ the\\ past\\ 4\\ months\\.\\ mri\\ was\\ ordered\\ to\\ evaluate\\ for\\ enhancing\\ plaques\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cells\\:\\ 0\\.20258946554115737\ \(0\)\
\-\ and\\:\\ 0\\.17658150434908948\ \(0\)\
\-\ spastic\\:\\ 0\\.17558246309970715\ \(0\)\
\-\ showed\\:\\ 0\\.1751348225563172\ \(0\)\
\-\ white\\:\\ 0\\.17347857040424167\ \(0\)\
\-\ oligoclonal\\:\\ 0\\.17095759966489812\ \(0\)\
\-\ foci\\:\\ 0\\.1611808490995682\ \(0\)\
\-\ hyperintensities\\:\\ 0\\.16092481124187835\ \(0\)\
\-\ blood\\:\\ 0\\.15270393760364784\ \(0\)\
\-\ t2\\:\\ 0\\.15127507745647162\ \(0\)\
\-\ acuity\\:\\ 0\\.1463470451814799\ \(0\)\
\-\ puncture\\:\\ 0\\.1436324960860403\ \(0\)\
\-\ sclerosis\\:\\ 0\\.1404633772531958\ \(0\)\
\-\ 2010\\:\\ 0\\.1400797808231458\ \(0\)\
\-\ bands\\:\\ 0\\.1395374727555695\ \(0\)\
\-\ mri\\:\\ 0\\.1349686710534114\ \(0\)\
\-\ plaques\\:\\ 0\\.1326408129351404\ \(0\)\
\-\ progressively\\:\\ 0\\.12863838526752716\ \(0\)\
\-\ multiple\\:\\ 0\\.12860834808014177\ \(0\)\
\-\ ataxia\\:\\ 0\\.1276575125792069\ \(0\)\
\-\ glucose\\:\\ 0\\.12702604761327324\ \(0\)\
\-\ red\\:\\ 0\\.1238320482219996\ \(0\)\
\-\ enhancing\\:\\ 0\\.12353588861031095\ \(0\)\
\-\ protein\\:\\ 0\\.12200816806183025\ \(0\)\
\-\ ordered\\:\\ 0\\.11550354805788532\ \(0\)\
\-\ scattered\\:\\ 0\\.11439707816781307\ \(0\)\
\-\ axial\\:\\ 0\\.11391152300620755\ \(0\)\
\-\ 48\\:\\ 0\\.11386314626950342\ \(0\)\
\-\ gait\\:\\ 0\\.11386314626950342\ \(0\)\
\-\ visual\\:\\ 0\\.11216774761488603\ \(0\)\
\-\ right\\:\\ 0\\.10896823603940639\ \(0\)\
\-\ lumbar\\:\\ 0\\.10615878175674881\ \(0\)\
\-\ eye\\:\\ 0\\.10517266216357181\ \(0\)\
\-\ trophy\\:\\ 0\\.10512348960440679\ \(0\)\
\-\ bilaeral\\:\\ 0\\.10512348960440679\ \(0\)\
\-\ evaluate\\:\\ 0\\.10223130978990384\ \(0\)\
\-\ sagittal\\:\\ 0\\.10109167392852506\ \(0\)\
\-\ periatrial\\:\\ 0\\.10045110645383853\ \(0\)\
\-\ worsening\\:\\ 0\\.10039473440297718\ \(0\)\
\-\ matter\\:\\ 0\\.10010237915734709\ \(0\)\
\-\ fair\\:\\ 0\\.09713599785099007\ \(0\)\
\-\ weakness\\:\\ 0\\.09594887792231313\ \(0\)\
\-\ diagnosed\\:\\ 0\\.09523233224544794\ \(0\)\
\-\ extremity\\:\\ 0\\.09469002417787163\ \(0\)\
\-\ now\\:\\ 0\\.09024685445746751\ \(0\)\
\-\ with\\:\\ 0\\.09010121289924819\ \(0\)\
\-\ interferon\\:\\ 0\\.08779123154985358\ \(0\)\
\-\ past\\:\\ 0\\.08557611486024301\ \(0\)\
\-\ patient\\:\\ 0\\.08552029867144627\ \(0\)\
\-\ in\\:\\ 0\\.08176282851744665\ \(0\)\
\-\ decreased\\:\\ 0\\.08143437577614791\ \(0\)\
\-\ the\\:\\ 0\\.07869827334694765\ \(0\)\
\-\ time\\:\\ 0\\.07792477938361114\ \(0\)\
\-\ presented\\:\\ 0\\.07666506533832469\ \(0\)\
\-\ months\\:\\ 0\\.07652538594421006\ \(0\)\
\-\ enhancement\\:\\ 0\\.07567106168612232\ \(0\)\
\-\ lesions\\:\\ 0\\.07550393238604529\ \(0\)\
\-\ signal\\:\\ 0\\.07452583527784322\ \(0\)\
\-\ over\\:\\ 0\\.07310234485300972\ \(0\)\
\-\ symptoms\\:\\ 0\\.07193219357317791\ \(0\)\
\-\ subcortical\\:\\ 0\\.07089387472117091\ \(0\)\
\-\ beta\\:\\ 0\\.06826353278012565\ \(0\)\
\-\ periventricular\\:\\ 0\\.06757876611832245\ \(0\)\
\-\ lower\\:\\ 0\\.06718061964307356\ \(0\)\
\-\ of\\:\\ 0\\.0643195782810523\ \(0\)\
\-\ hemispheres\\:\\ 0\\.06382875628960345\ \(0\)\
\-\ presents\\:\\ 0\\.06324320289528308\ \(0\)\
\-\ interval\\:\\ 0\\.05948100065505023\ \(0\)\
\-\ parenchymal\\:\\ 0\\.059050164878063555\ \(0\)\
\-\ male\\:\\ 0\\.05853489674823095\ \(0\)\
\-\ that\\:\\ 0\\.05705246030695368\ \(0\)\
\-\ numerous\\:\\ 0\\.05552553205321992\ \(0\)\
\-\ lobes\\:\\ 0\\.0548452582817492\ \(0\)\
\-\ gadolinium\\:\\ 0\\.05477209286299516\ \(0\)\
\-\ development\\:\\ 0\\.05434259539560197\ \(0\)\
\-\ normal\\:\\ 0\\.053677764955461386\ \(0\)\
\-\ parietal\\:\\ 0\\.053079390878374405\ \(0\)\
\-\ coronal\\:\\ 0\\.05234749321123152\ \(0\)\
\-\ administration\\:\\ 0\\.05234749321123152\ \(0\)\
\-\ there\\:\\ 0\\.05231096460395704\ \(0\)\
\-\ deep\\:\\ 0\\.05116888138561848\ \(0\)\
\-\ additional\\:\\ 0\\.050957434815676265\ \(0\)\
\-\ are\\:\\ 0\\.049886370443724654\ \(0\)\
\-\ at\\:\\ 0\\.04965737039589664\ \(0\)\
\-\ abnormalities\\:\\ 0\\.04761616612272397\ \(0\)\
\-\ was\\:\\ 0\\.04581812330361281\ \(0\)\
\-\ new\\:\\ 0\\.04547605185534999\ \(0\)\
\-\ several\\:\\ 0\\.043128163141535204\ \(0\)\
\-\ frontal\\:\\ 0\\.04230836762664677\ \(0\)\
\-\ diffuse\\:\\ 0\\.04122355557707311\ \(0\)\
\-\ brain\\:\\ 0\\.040978602079199754\ \(0\)\
\-\ t1\\:\\ 0\\.04095658962791829\ \(0\)\
\-\ year\\:\\ 0\\.040516047037967615\ \(0\)\
\-\ for\\:\\ 0\\.03984713638091469\ \(0\)\
\-\ changes\\:\\ 0\\.03972708243739862\ \(0\)\
\-\ following\\:\\ 0\\.03943434405166421\ \(0\)\
\-\ through\\:\\ 0\\.03913007516106577\ \(0\)\
\-\ old\\:\\ 0\\.03890943013418302\ \(0\)\
\-\ performed\\:\\ 0\\.03888863894572151\ \(0\)\
\-\ post\\:\\ 0\\.035768141972287386\ \(0\)\
\-\ noted\\:\\ 0\\.03485224071729841\ \(0\)\
\-\ were\\:\\ 0\\.0338841430468245\ \(0\)\
\-\ to\\:\\ 0\\.03286690223169336\ \(0\)\
\-\ contrast\\:\\ 0\\.031938964424384236\ \(0\)\
\-\ also\\:\\ 0\\.030919540675446684\ \(0\)\
\-\ images\\:\\ 0\\.03040649980671582\ \(0\)\
\-\ within\\:\\ 0\\.030275201218688323\ \(0\)\
\-\ is\\:\\ 0\\.018001790391944487\ \(0\)\
